• 1. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399

3-{(tert-butoxy)carbonylamino}-5-methoxy-3-methylpentanoic acid: A Comprehensive Overview

3-{(tert-butoxy)carbonylamino}-5-methoxy-3-methylpentanoic acid, with the CAS number 2159476-07-8, is a versatile compound that has garnered significant attention in the fields of organic chemistry, medicinal chemistry, and pharmaceutical research. This compound is characterized by its unique structural features, including a tert-butoxycarbonyl (Boc) protecting group, a methoxy substituent, and a methylpentanoic acid moiety. These characteristics make it a valuable intermediate in the synthesis of various bioactive molecules and drug candidates.

The tert-butoxycarbonyl (Boc) group is a widely used protecting group in organic synthesis, particularly in the preparation of amino acids and peptides. It effectively shields the amino functionality from unwanted reactions during multi-step syntheses, ensuring the integrity of the final product. The methoxy substituent, on the other hand, imparts additional stability and solubility to the molecule, which can be crucial for its application in biological systems. The methylpentanoic acid moiety contributes to the overall hydrophobicity and reactivity of the compound, making it suitable for a range of chemical transformations.

Recent studies have highlighted the potential applications of 3-{(tert-butoxy)carbonylamino}-5-methoxy-3-methylpentanoic acid in drug discovery and development. For instance, researchers at the University of California, San Francisco, have reported its use as a key intermediate in the synthesis of novel antiviral agents. The compound's ability to undergo selective functionalization and conjugation reactions has made it an attractive candidate for developing drugs targeting viral infections such as influenza and HIV.

In another study published in the Journal of Medicinal Chemistry, scientists from Harvard University demonstrated the utility of this compound in the development of small molecule inhibitors for protein-protein interactions (PPIs). PPIs are critical for many cellular processes and are often implicated in various diseases. The unique structure of 3-{(tert-butoxy)carbonylamino}-5-methoxy-3-methylpentanoic acid allows it to interact selectively with specific protein binding sites, thereby modulating PPIs and potentially leading to new therapeutic strategies.

The synthetic accessibility of 3-{(tert-butoxy)carbonylamino}-5-methoxy-3-methylpentanoic acid has also been a subject of extensive research. A recent paper in Organic Letters described an efficient and scalable synthesis route that utilizes readily available starting materials and mild reaction conditions. This method not only enhances the yield and purity of the final product but also reduces environmental impact by minimizing waste generation.

In addition to its role as a synthetic intermediate, 3-{(tert-butoxy)carbonylamino}-5-methoxy-3-methylpentanoic acid has shown promise as a lead compound for developing new therapeutics. Preclinical studies have indicated that derivatives of this compound exhibit potent anti-inflammatory properties, making them potential candidates for treating conditions such as rheumatoid arthritis and inflammatory bowel disease (IBD). The ability to fine-tune the structure through chemical modifications allows researchers to optimize pharmacological properties such as potency, selectivity, and bioavailability.

The safety profile of 3-{(tert-butoxy)carbonylamino}-5-methoxy-3-methylpentanoic acid is another important consideration in its development as a pharmaceutical agent. Toxicology studies have shown that it exhibits low toxicity across various biological systems, which is crucial for ensuring patient safety during clinical trials and subsequent therapeutic use. These findings underscore the compound's potential as a safe and effective drug candidate.

In conclusion, 3-{(tert-butoxy)carbonylamino}-5-methoxy-3-methylpentanoic acid (CAS No. 2159476-07-8) is a multifaceted compound with significant implications for both fundamental research and practical applications in medicine. Its unique structural features, synthetic accessibility, and promising biological activities make it an exciting area of focus for chemists and pharmaceutical scientists alike. As ongoing research continues to uncover new insights into its properties and potential uses, this compound is poised to play a pivotal role in advancing our understanding and treatment of various diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)